Lazard Q3 Earnings Beat Estimates, Advisory Revenues & AUM Rise Y/Y — Positive
LAZ Zacks Investment Research — October 24, 2025LAZ's Q3 earnings top estimates as advisory and asset management revenues rose y/y, supported by higher AUM and solid liquidity.
Top Stock Movers Now: Ford Motor, AMD, Deckers Outdoor, Newmont, and More — Positive
AMD DECK F NEM Investopedia — October 24, 2025The Dow, S&P 500, and Nasdaq climbed to record highs in intraday trading Friday after a flurry of strong corporate earnings and the release of a cooler-than-expected inflation report.
Wall Street Roundup: Are We In A Bubble? — Neutral
AAPL BYND DIA DNUT GM GOOG GOOGL GPRO INTC IRBT MEME META MSFT NDAQ NFLX NVDA QQQ SPY TSLA WMT Seeking Alpha — October 24, 2025Tesla (TSLA) earnings were mixed, with margin pressure and near-term uncertainty, but revenue beat expectations and investors remain in wait-and-see mode. GM surged 15% after beating earnings and raising guidance, as tariff impacts were less severe and market share reached a multi-year high.
Alphabet Q3 2025 Earnings Preview: Anthropic Deal Signals Next Phase Of Cloud Acceleration — Positive
GOOG GOOGL Seeking Alpha — October 24, 2025Alphabet has been the best-performing Magnificent 7 stock this year, supported by robust Google Cloud and AI advancements. Momentum was recently reinforced by Anthropic's endorsement of additional compute capacity on Google's in-house TPUs, validating diversification of growth opportunities for its cloud unit. This is expected to reinforce Google Cloud's market share gains, and narrow the lead currently commanded by rivals Microsoft Azure and Amazon Web Services.
Relay Therapeutics Is A Buy For Its Superb Safety Data — Positive
RLAY Seeking Alpha — October 24, 2025Relay Therapeutics leads with RLY-2608, an allosteric PI3Kα inhibitor showing superior safety and efficacy in advanced breast cancer. RLY-2608's phase 1/2 trial data demonstrates higher response rates and significantly lower toxicity compared to existing therapies like alpelisib and inavolisib. The Eli Lilly acquisition of STX-478 from Scorpion Therapeutics highlights the value of allosteric PI3Kα inhibitors, positioning RLAY as undervalued and ahead in clinical development.
Santee Cooper Selects Brookfield Asset Management to Proceed with Nuclear Project — Neutral
BAM Business Wire — October 24, 2025MONCKS CORNER, S.C.--(BUSINESS WIRE)--After a thorough, expert-driven review of proposals from global leaders in the nuclear power industry, the Santee Cooper Board of Directors approved today a letter of intent with Brookfield Asset Management (“Brookfield”) to guide final, exclusive negotiations with Brookfield concerning the two partially built AP1000 nuclear units in Fairfield County, SC. The letter of intent establishes a six-week initial project feasibility period. In that period, the par.
Majority Grindr Shareholders George Raymond Zage III and James Fu Bin Lu Submit Non-Binding Offer to Acquire All Outstanding Shares of Grindr Inc. for $18.00 per Share — Neutral
GRND PRNewsWire — October 24, 2025Proposed Offer Represents 51% Premium to Unaffected Stock Price LOS ANGELES , Oct. 24, 2025 /PRNewswire/ -- George Raymond Zage III and James Fu Bin Lu (together, the "Proposing Shareholders"), who along with affiliated entities beneficially own in aggregate more than 60% of the outstanding shares of common stock of Grindr Inc. (the "Company" or "Grindr") (NYSE: GRND), today submitted a non-binding proposal (the "Proposal") to acquire all outstanding shares of the Company's common stock not already owned by the Proposing Shareholders and their affiliates (the "Minority Shares") in a going-private transaction (the "Acquisition"). The Proposal contemplates consideration of $18.00 …
Hilltop Holdings Q3 Earnings Beat on Y/Y Increase in Revenues — Positive
HTH Zacks Investment Research — October 24, 2025HTH posts a strong Q3 beat as higher interest income, better credit quality and loan growth boost results despite rising expenses.
Why Amphenol (APH) Might be Well Poised for a Surge — Positive
APH Zacks Investment Research — October 24, 2025Amphenol (APH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Pagaya: The Foundation Is Set For A Long-Term Rerating — Positive
PGY Seeking Alpha — October 24, 2025Pagaya leverages AI to serve high-risk borrowers rejected by traditional banks, tapping into a vast underserved market. PGY has achieved GAAP profitability in the last two quarters, with operational leverage. PGY's strong partnerships, robust credit quality, and scalable business model support a positive long-term outlook and continued network volume growth.
Orion Spacecraft Completes Major Stacking Milestone Ahead of Artemis II Mission — Neutral
LMT PRNewsWire — October 24, 2025Orion Integrity spacecraft connected with the SLS rocket, readying for historic crewed journey to the Moon KENNEDY SPACE CENTER, Fla. , Oct. 24, 2025 /PRNewswire/ -- In a move signifying mission readiness, NASA's Exploration Ground Systems (EGS) team recently joined and connected the Lockheed Martin (NYSE: LMT)-developed Orion spacecraft with the Space Launch System (SLS) rocket for the upcoming Artemis II mission.
Baker Hughes Company (BKR) Q3 2025 Earnings Call Transcript — Neutral
BKR Seeking Alpha — October 24, 2025Baker Hughes Company (NASDAQ:BKR ) Q3 2025 Earnings Call October 24, 2025 9:30 AM EDT Company Participants Chase Mulvehill - Vice President of Investor Relations Lorenzo Simonelli - Chairman, President & CEO Ahmed Moghal - Executive VP & CFO Conference Call Participants John Anderson - Barclays Bank PLC, Research Division Arun Jayaram - JPMorgan Chase & Co, Research Division Stephen Gengaro - Stifel, Nicolaus & Company, Incorporated, Research Division Scott Gruber - Citigroup Inc., Research Division James West - Melius Research LLC Marc Bianchi - TD Cowen, Research Division Presentation Operator Good day, ladies and gentlemen, and welcome to the …
Deckers Brands stock sinks more than 12% after soft outlook raises concerns about Hoka, Ugg growth — Negative
DECK CNBC — October 24, 2025Deckers Brands fiscal Q2 earnings of $1.82 per share beat estimates, but full-year revenue guidance missed Wall Street's forecast. Sales of HOKA running shoes softened, while UGG boots outperformed expectations.
PGY vs. OMF: Which Consumer Credit Stock Is Better Placed for Growth? — Positive
OMF PGY Zacks Investment Research — October 24, 2025Pagaya leans on AI and asset-light growth, while OneMain bets on brick-and-mortar lending and shareholder returns.
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference — Neutral
SION GlobeNewsWire — October 24, 2025Phase 1 data of first-in-class NBD1 stabilizers, SION-719 and SION-451, demonstrated they were generally well tolerated and exceeded desired pharmacokinetic targets New preclinical data show that NBD1 stabilizers restored the half-life of F508del-CFTR up to wild-type levels WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced data presented at the 2025 North American Cystic Fibrosis Conference (NACFC) being held in …
Will Global Payments (GPN) Beat Estimates Again in Its Next Earnings Report? — Positive
GPN Zacks Investment Research — October 24, 2025Global Payments (GPN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Dutch Bros (BROS) Beat Estimates Again in Its Next Earnings Report? — Positive
BROS Zacks Investment Research — October 24, 2025Dutch Bros (BROS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Axos Financial (AX) Beat Estimates Again in Its Next Earnings Report? — Positive
AX Zacks Investment Research — October 24, 2025Axos Financial (AX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Cushman & Wakefield (CWK) Beat Estimates Again in Its Next Earnings Report? — Positive
CWK Zacks Investment Research — October 24, 2025Cushman & Wakefield (CWK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.